Literature DB >> 9453614

A murine model in which protection correlates with pertussis vaccine efficacy in children reveals complementary roles for humoral and cell-mediated immunity in protection against Bordetella pertussis.

K H Mills1, M Ryan, E Ryan, B P Mahon.   

Abstract

The results of phase 3 efficacy trials have shown that acellular and whole-cell pertussis vaccines can confer protection against whooping cough. However, despite the advances in vaccine development, clinical trials have not provided significant new information on the mechanism of protective immunity against Bordetella pertussis. Classical approaches based on measurement of antibody responses to individual antigens failed to define an immunological correlate of protection. A reliable animal model, predictive of acellular and whole-cell pertussis vaccine potency in children, would facilitate an elucidation of the mechanism of immune protection against B. pertussis and would assist in the regulatory control and future development of pertussis vaccines. In this study, we have shown that the rate of B. pertussis clearance following respiratory challenge of immunized mice correlated with vaccine efficacy in children. Using this model together with mice with targeted disruptions of the gamma interferon (IFN-gamma) receptor, interleukin-4 or immunoglobulin heavy-chain genes, we have demonstrated an absolute requirement for B cells or their products in bacterial clearance and a role for IFN-gamma in immunity generated by previous infection or immunization with the whole-cell pertussis vaccine. The results of passive immunization experiments suggested that protection early after immunization with acellular pertussis vaccines is mediated by antibody against multiple protective antigens. In contrast, more complete protection conferred by previous infection or immunization with whole-cell pertussis vaccines reflected the induction of Th1 cells. Our findings suggest that the mechanism of immunity against B. pertussis involves humoral and cellular immune responses which are not directed against a single protective antigen and thus provide an explanation for previous failures to define an immunological correlate of protection.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9453614      PMCID: PMC107945          DOI: 10.1128/IAI.66.2.594-602.1998

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  38 in total

1.  Effect of schedule on reactogenicity and antibody persistence of acellular and whole-cell pertussis vaccines: value of laboratory tests as predictors of clinical performance.

Authors:  E Miller; L A Ashworth; K Redhead; C Thornton; P A Waight; T Coleman
Journal:  Vaccine       Date:  1997-01       Impact factor: 3.641

2.  Distinct T-cell subtypes induced with whole cell and acellular pertussis vaccines in children.

Authors:  M Ryan; G Murphy; E Ryan; L Nilsson; F Shackley; L Gothefors; K Oymar; E Miller; J Storsaeter; K H Mills
Journal:  Immunology       Date:  1998-01       Impact factor: 7.397

3.  Effects of recombinant human gamma interferon on intracellular survival of Bordetella pertussis in human phagocytic cells.

Authors:  D Torre; G Ferrario; G Bonetta; L Perversi; R Tambini; F Speranza
Journal:  FEMS Immunol Med Microbiol       Date:  1994-09

4.  Vaccine- and antigen-dependent type 1 and type 2 cytokine induction after primary vaccination of infants with whole-cell or acellular pertussis vaccines.

Authors:  C M Ausiello; F Urbani; A la Sala; R Lande; A Cassone
Journal:  Infect Immun       Date:  1997-06       Impact factor: 3.441

5.  Cell-mediated and antibody responses to Bordetella pertussis antigens in children vaccinated with acellular or whole-cell pertussis vaccines. The Progetto Pertosse-CMI Working Group.

Authors:  A Cassone; C M Ausiello; F Urbani; R Lande; M Giuliano; A La Sala; A Piscitelli; S Salmaso
Journal:  Arch Pediatr Adolesc Med       Date:  1997-03

6.  Effective immunization against Bordetella pertussis respiratory infection in mice is dependent on induction of cell-mediated immunity.

Authors:  K Redhead; J Watkins; A Barnard; K H Mills
Journal:  Infect Immun       Date:  1993-08       Impact factor: 3.441

7.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin mu chain gene.

Authors:  D Kitamura; J Roes; R Kühn; K Rajewsky
Journal:  Nature       Date:  1991-04-04       Impact factor: 49.962

8.  Bordetella pertussis respiratory tract infection in the mouse: pathophysiological responses.

Authors:  M Pittman; B L Furman; A C Wardlaw
Journal:  J Infect Dis       Date:  1980-07       Impact factor: 5.226

9.  Cell-mediated immunity to Bordetella pertussis: role of Th1 cells in bacterial clearance in a murine respiratory infection model.

Authors:  K H Mills; A Barnard; J Watkins; K Redhead
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

10.  B lymphocytes can be competent antigen-presenting cells for priming CD4+ T cells to protein antigens in vivo.

Authors:  S Constant; N Schweitzer; J West; P Ranney; K Bottomly
Journal:  J Immunol       Date:  1995-10-15       Impact factor: 5.422

View more
  84 in total

1.  Cell-mediated immune responses in four-year-old children after primary immunization with acellular pertussis vaccines.

Authors:  C M Ausiello; R Lande; F Urbani; A la Sala; P Stefanelli; S Salmaso; P Mastrantonio; A Cassone
Journal:  Infect Immun       Date:  1999-08       Impact factor: 3.441

2.  Phagocytosed Bordetella pertussis fails to survive in human neutrophils.

Authors:  D H Lenz; C L Weingart; A A Weiss
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

3.  Long-term pertussis-specific immunity after primary vaccination with a combined diphtheria, tetanus, tricomponent acellular pertussis, and hepatitis B vaccine in comparison with that after natural infection.

Authors:  S Esposito; T Agliardi; A Giammanco; G Faldella; A Cascio; S Bosis; O Friscia; M Clerici; N Principi
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

4.  Vaccination with Bordetella pertussis-pulsed autologous or heterologous dendritic cells induces a mucosal antibody response in vivo and protects against infection.

Authors:  A George-Chandy; N Mielcarek; I Nordström; J Holmgren; K Eriksson
Journal:  Infect Immun       Date:  2001-06       Impact factor: 3.441

5.  Booster immunization of children with an acellular pertussis vaccine enhances Th2 cytokine production and serum IgE responses against pertussis toxin but not against common allergens.

Authors:  E J Ryan; L Nilsson; N Kjellman; L Gothefors; K H Mills
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

6.  Cross-species protection mediated by a Bordetella bronchiseptica strain lacking antigenic homologs present in acellular pertussis vaccines.

Authors:  Neelima Sukumar; Gina Parise Sloan; Matt S Conover; Cheraton F Love; Seema Mattoo; Nancy D Kock; Rajendar Deora
Journal:  Infect Immun       Date:  2010-02-22       Impact factor: 3.441

7.  Bordetella pertussis-infected human monocyte-derived dendritic cells undergo maturation and induce Th1 polarization and interleukin-23 expression.

Authors:  Giorgio Fedele; Paola Stefanelli; Fabiana Spensieri; Cecilia Fazio; Paola Mastrantonio; Clara M Ausiello
Journal:  Infect Immun       Date:  2005-03       Impact factor: 3.441

8.  Cellular immunity in adolescents and adults following acellular pertussis vaccine administration.

Authors:  Claudius U Meyer; Fred Zepp; Michael Decker; Martin Lee; Swei-Ju Chang; Joel Ward; Sandra Yoder; Hugues Bogaert; Kathryn M Edwards
Journal:  Clin Vaccine Immunol       Date:  2007-01-31

9.  Host genetics of Bordetella pertussis infection in mice: significance of Toll-like receptor 4 in genetic susceptibility and pathobiology.

Authors:  H A Banus; R J Vandebriel; H de Ruiter; J A M A Dormans; N J Nagelkerke; F R Mooi; B Hoebee; H J van Kranen; T G Kimman
Journal:  Infect Immun       Date:  2006-05       Impact factor: 3.441

10.  Acellular pertussis vaccine protects against exacerbation of allergic asthma due to Bordetella pertussis in a murine model.

Authors:  Darren P Ennis; Joseph P Cassidy; Bernard P Mahon
Journal:  Clin Diagn Lab Immunol       Date:  2005-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.